Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $38.80 USD
Change Today 0.00 / 0.00%
Volume 204.6K
CYNO On Other Exchanges
Symbol
Exchange
CYNO is not on other exchanges.
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

cynosure inc-a (CYNO) Snapshot

Open
$38.78
Previous Close
$38.80
Day High
$39.46
Day Low
$38.47
52 Week High
07/23/15 - $42.97
52 Week Low
10/15/14 - $19.04
Market Cap
859.8M
Average Volume 10 Days
278.7K
EPS TTM
$1.66
Shares Outstanding
22.2M
EX-Date
--
P/E TM
23.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for CYNOSURE INC-A (CYNO)

cynosure inc-a (CYNO) Related Businessweek News

View More BusinessWeek News

cynosure inc-a (CYNO) Details

Cynosure, Inc. develops and markets aesthetic treatment systems for plastic surgeons, dermatologists, and other medical practitioners. It offers Elite product line for hair removal, and treatment of facial and leg veins and pigmentations; SmartLipo product line for LaserBodySculpting for the removal of unwanted fat; Cellulaze product line for the treatment of cellulite; Affirm/SmartSkin product line for anti-aging applications, including treatments for wrinkles, skin texture, skin discoloration, and skin tightening; and Cynergy product line for the treatment of vascular lesions. The company also provides Accolade, MedLite C6, and RevLite product lines for the removal of benign pigmented lesions, as well as multi-colored tattoos; PicoSure product line for the treatment of tattoos, benign pigmented lesions, acne scars, fine lines, and wrinkles; Icon aesthetic system for hair removal, wrinkle reduction, and scar and stretch mark treatment; and Vectus diode laser for high volume hair removal. In addition, it distributes PinPointe FootLaser for the treatment of onychomycosis. The company’s aesthetic treatment systems utilizes a range of energy sources, including Pulse dye, Alexandrite, CO2, Diode, Erbium, Er:YAG, and Nd:YAG lasers; and intense pulsed light devices. It sells its products through a direct sales force in North America, France, Morocco, Germany, Spain, the United Kingdom, Australia, China, Japan, and Korea, as well as through independent distributors in approximately 120 countries. The company was founded in 1991 and is headquartered in Westford, Massachusetts.

755 Employees
Last Reported Date: 03/13/15
Founded in 1991

cynosure inc-a (CYNO) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $2.1M
President, Chief Operating Officer, Chief Fin...
Total Annual Compensation: $1.4M
Executive Vice President of Worldwide Sales
Total Annual Compensation: $1.0M
Compensation as of Fiscal Year 2014.

cynosure inc-a (CYNO) Key Developments

Cynosure, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Cynosure, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenue of $83.69 million compared to $72.57 million a year ago. Income from operations was $7.64 million compared to $6.40 million a year ago. Income before income taxes was $7.70 million compared to $6.27 million a year ago. Net income was $5.36 million or $0.24 per diluted share compared to $4.58 million or $0.20 per diluted share a year ago. Non-GAAP Income from operations was $9.93 million compared to $10.28 million a year ago. Non-GAAP net income was $6.69 million or $0.30 per diluted share compared to $6.96 million or $0.31 per diluted share a year ago. For the six months, the company reported revenue of $158.61 million compared to $134.58 million a year ago. Income from operations was $9.69 million compared to $7.74 million a year ago. Income before income taxes was $7.68 million compared to $7.33 million a year ago. Net income was $5.35 million or $0.24 per diluted share compared to $5.26 million or $0.23 per diluted share a year ago. Non-GAAP Income from operations was $15.03 million compared to $15.18 million a year ago. Non-GAAP net income was $9.99 million or $0.45 per diluted share compared to $10.14 million or $0.45 per diluted share a year ago.

Cynosure, Inc., Q2 2015 Earnings Call, Jul 28, 2015

Cynosure, Inc., Q2 2015 Earnings Call, Jul 28, 2015

Cynosure, Inc. to Report Q2, 2015 Results on Jul 28, 2015

Cynosure, Inc. announced that they will report Q2, 2015 results at 9:00 AM, Eastern Standard Time on Jul 28, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYNO:US $38.80 USD 0.00

CYNO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dynatronics Corp $3.18 USD +0.0599
Koninklijke Philips NV €25.32 EUR -0.005
Lutronic Corp 53,800 KRW +4,750
PhotoMedex Inc $1.11 USD +0.04
Zeltiq Aesthetics Inc $34.35 USD +2.24
View Industry Companies
 

Industry Analysis

CYNO

Industry Average

Valuation CYNO Industry Range
Price/Earnings 27.3x
Price/Sales 2.7x
Price/Book 2.2x
Price/Cash Flow 25.0x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYNOSURE INC-A, please visit www.cynosure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.